CORC

在结果中检索

CORC

浏览/检索结果: 共22条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping
收藏  |  浏览/下载：31/0  |  提交时间：2022/05/16
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文
BLOOD ADVANCES, 2022, 卷号: 6
作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili
收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23
Detachable Liposomes Combined Immunochemotherapy for Enhanced Triple-Negative Breast Cancer Treatment through Reprogramming of Tumor-Associated Macrophages 期刊论文
NANO LETTERS, 2021, 卷号: 21, 期号: 14, 页码: 6031-6041
作者:  Chen, Mingshu;  Miao, Yunqiu;  Qian, Kun;  Zhou, Xin;  Guo, Linmiao
收藏  |  浏览/下载：28/0  |  提交时间：2021/11/04
Clinical features, treatment and risk factors for interstitial pneumonia in B-cell non-Hodgkin lymphoma patients 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:  Li, Cong;  Lu, Fangxiao;  Lei, Tao;  Yu, Haifeng;  Yang, Haiyan
收藏  |  浏览/下载：22/0  |  提交时间：2020/11/30
NLG919/cyclodextrin complexation and anti-cancer therapeutic benefit as a potential immunotherapy in combination with paclitaxel 期刊论文
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 卷号: 138, 页码: 8
作者:  Xu, Jian;  Ren, Xiaohong;  Guo, Tao;  Sun, Xian;  Chen, Xiaojin
收藏  |  浏览/下载：7/0  |  提交时间：2020/07/01
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy 期刊论文
BLOOD, 2019, 卷号: 133, 期号: 2
作者:  Kusumoto, Shigeru;  Arcaini, Luca;  Hong, Xiaonan;  Jin, Jie;  Kim, Won Seog
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy. 期刊论文
Immunotherapy, 2019
作者:  Li Qing;  Huang Jingcao;  Ou Yang;  Li Yan;  Wu Yu
收藏  |  浏览/下载：32/0  |  提交时间：2019/02/25
Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer 期刊论文
JOURNAL OF NANOBIOTECHNOLOGY, 2019, 卷号: 17, 期号: 1
作者:  Yuan, Shen-Jun;  Xu, Yong-Hong;  Wang, Chao;  An, Hui-Chao;  Xu, Hua-Zhen
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Nanotechnology-mediated immunochemotherapy with Ingenol-3-Mebutate for Systematic Anti-tumor Effects 期刊论文
JOURNAL OF CONTROLLED RELEASE, 2019, 卷号: 304, 页码: 242-258
作者:  Yu, Mian;  Zhao, Miaoqing;  Yu, Rilei;  Chu, Shaochen;  Xu, Jiahao
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/11
Enzyme responsiveness enhances the specificity and effectiveness of nanoparticles for the treatment of B16F10 melanoma 期刊论文
Journal of Controlled Release, 2019, 卷号: 316, 页码: 208-222
作者:  Huang, Yi;  Shi, Yanbin;  Wang, Qingjie;  Qi, Tongtong;  Fu, Xianglei
收藏  |  浏览/下载：42/0  |  提交时间：2019/12/11

©版权所有 ©2017 CSpace - Powered by CSpace